Vanberra Signal

Cofactor Genomics

Curated by Signal

Developer of diagnostic assays using RNA sequencing

Overview

Developer of diagnostic assays using RNA sequencing. The company's product includes ImmunoPrism is an RNA sequencing-based assay that uses predictive immune modeling to generate multidimensional biomarkers. It combines machine learning and RNA-sequencing to build gene expression models for immune cells. The company's models for key immune cells include Immune Health Expression Models, Immune Escape Genes, and Co-inhibitory molecules. The company's sequencing products include mRNAble, Total RNAble, picoRNA, FFPExact, miRNAble, RNAccess, RNAmplify, and RNAdvantage.

Key facts

Founded
2009

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of emergency medical alert systems for senior care

    Life Sciences TechnologyWilliamsport, United States
  • Provider of in-vitro fertilization device for artificial insemination

    Life Sciences TechnologyIndianapolis, United States
  • Manufacturer of portable MRI systems for doctors

    Life Sciences TechnologyNew York City, United States

About Cofactor Genomics

What does Cofactor Genomics do?

Developer of diagnostic assays using RNA sequencing.

Where is Cofactor Genomics headquartered?

Cofactor Genomics is headquartered in San Francisco, United States.

When was Cofactor Genomics founded?

Cofactor Genomics was founded in 2009.

Which sector is Cofactor Genomics in?

Cofactor Genomics operates in Life Sciences Technology.

Who are Cofactor Genomics's competitors?

Companies similar to Cofactor Genomics include Alert 1, Fertiligent, and Hyperfine.